1J5 — Hyphens Pharma International Balance Sheet
0.000.00%
Last trade - 00:00
- SG$88.12m
- SG$74.36m
- SG$170.60m
- 61
- 74
- 84
- 89
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | Interim Report | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 26.2 | 27.5 | 19.5 | 36.5 | 23.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 28.7 | 23.7 | 28.7 | 31.1 | 41.1 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 66.6 | 68.7 | 74.1 | 89.7 | 92.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5.95 | 4.81 | 4.41 | 3.02 | 4.86 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 80.1 | 81.5 | 99.2 | 114 | 121 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 33.1 | 30.3 | 42.6 | 40.1 | 49.2 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Liabilities | 36.1 | 34.3 | 44.5 | 45.4 | 57.8 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 44.1 | 47.2 | 54.7 | 69 | 63 |
Total Liabilities & Shareholders' Equity | 80.1 | 81.5 | 99.2 | 114 | 121 |
Total Common Shares Outstanding |